Epicrispr Biotechnologies

At this time, Epicrispr believes the most appropriate and scientifically sound way for patients to access our investigational therapies is through participation in our clinical trials. This ensures the collection of critical safety and efficacy data needed to advance our development programs and make these therapies broadly available as quickly and responsibly as possible